PURPOSE. The proliferation of new blood vessels in the retina is a leading cause of vision impairment. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) is involved in cell signaling for ischemia-induced angiogenesis, but its role in retinal neovascularization is unclear. We have analyzed the dependence of retinal neovascularization on the Nox2 isoform in oxygen-induced retinopathy (OIR) in mice.
R
etinal neovascularization remains a leading cause of serious loss of vision in conditions, such as retinopathy of prematurity and diabetic retinopathy. Pathologic retinal neovascularization typically occurs in the context of retinal hypoxia that is a consequence of the loss of preexisting vessels, or the cessation of retinal vascular development. The new vessels formed in these processes are prone to hemorrhage and are hyperpermeable, leading to retinal edema, as well as lipid and protein exudation. 1 The VEGF has been identified as a key mediator of these processes: it has long been known that levels of VEGF are significantly higher in the ocular fluids and tissues of patients with proliferative retinopathy than in those of unaffected individuals, 2, 3 and the advent of intravitreally administered inhibitors of VEGF has revolutionized the clinical management of these disorders. However, current approaches that target VEGF remain far from ideal for several reasons, including the need for repeated intravitreal injections, often for indefinite periods, the potential for deleterious effects on the choroidal vasculature, and the emergence of treatment resistance. 2, 3 There remains a strong case for better elucidation of the molecular pathways of retinal neovascularization, and the development of alternative or adjunctive therapies to tackle these destructive process.
One of the animal models used to study the mechanisms underlying retinal neovascularization is oxygen-induced retinopathy (OIR) in the mouse, where VEGF has a significant role. 4, 5 Using an OIR model, Al-Shabrawey et al. 6 demonstrated that neovascularization in the mouse was associated with increases in VEGF expression and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox)-generated reactive oxygen species (ROS). The antioxidant apocynin, which also blocks Nox activation, suppressed ROS generation, retinal VEGF expression, and neovascularization in this OIR model. 6 Knockdown of Nox4 gene expression with Nox4 RNAi also has been demonstrated to suppress VEGF-associated retinal leakage in diabetic mice. 7 These and other studies suggest that Nox-generated ROS signaling may be crucial for VEGF-driven angiogenesis and vascular leakage. Several isoforms of the Nox catalytic subunit have been identified, and the prototypical Nox2 is composed of membrane-bound Nox2 and p22phox subunits, as well as the cytosolic subunits p40phox, p47phox, p67phox, and small GTPase Rac (see Supplementary Fig. S1 ). In addition, VEGF has been shown to stimulate an increase in ROS generation via an activation of the catalytic domain of Nox2 to regulate angiogenesis in the ischemic hind limb, in sponge models of angiogenesis, and in an in vivo tissue engineering chamber that we have used to grow new tissues. [8] [9] [10] Thus, ROS appear to act as downstream mediators of VEGF-mediated signaling in angiogenesis in a range of tissues. The precise roles played by the different Nox isoforms in angiogenesis, especially in the retina, remains to be defined. Nox2 is expressed in inflammatory and endothelial cells, and both cell types have been shown to have a role in angiogenic responses including neovascularization in mouse OIR. 6, 11 Therefore, we hypothesized that Nox2 has an important role in retinal neovascularization in OIR. A better understanding of the molecular pathways of retinal neovascularization may pave the way to new therapies for blinding eye diseases. 0 ; Sigma-Aldrich, Sydney, New South Wales, Australia). The OIR was induced by exposing 7-day-old neonatal mice (P7) and their mothers to 75% oxygen for 5 days (74.91 6 0.05% oxygen, n ¼ 95, P7-P12) followed by a 5-day period in room air (P12-P17). 4, 13 Oxygen levels were monitored with an external oxygen analyzer (Model No. 500-AE; Sensidyne, St. Petersburg, FL) and recordings were analyzed. Neonatal mice were sacrificed, and eyes were harvested at P8 and P17, time points corresponding with periods of peak vaso-obliteration and neovascularization, respectively. 4, 14 Eyes were fixed in 4% paraformaldehyde (PFA; ProSciTech, Kirwan, Queensland, Australia) for 1 hour, and retinal flat mounts were prepared and stained with fluorophore-conjugated isolectin B4 (5 g/ mL, Alexa Fluor 488 No. I21411; Life Technologies, Mulgrave, Victoria, Australia) overnight at 48C. 4, 13 Flat mounts then were washed in PBS and mounted in fluorescent mounting media (Dako, Glostrup, Denmark). Images of each retinal flat mount were captured with a fluorescence microscope (34 objective magnification, emission 495 nm, excitation 510 nm; Olympus, Victoria, Australia), and the degree of vasoobliteration and neovascularization then was quantified as described previously. 4 Avascular areas and regions of neovascularization in images of retinal flat mounts were delineated and measured using ImageJ (National Institutes of Health, Bethesda, MD), 15 and expressed as a percentage of the total retinal area. Age-matched neonatal mice exposed to room air were used as normoxic controls. One eye was used for flat mount preparation, while the fellow eye was used either for gene expression analysis or in situ superoxide detection.
MATERIALS AND METHODS

Mouse Model of Oxygen Induced Retinopathy
Gene Expression Detected by Real-Time PCR
Total retinal RNA was purified using commercial kits in accordance with the manufacturer's instructions (RNeasy Mini Kit; Qiagen, Victoria, Australia). Briefly, a single retina was lysed and homogenized, and RNA in the lysate was purified using a column system. The RNA was reverse-transcribed to cDNA (100 ng) using a high capacity cDNA reverse transcription kit (catalogue No. 4374996; Life Technologies). Real-time PCR were performed (7300 real-time PCR systems; Life Technologies) using a TaqMan Universal PCR master mix, and commercially available TaqMan gene expression assays for mouse Nox2 (Mm00432775_m1; Life Technologies) and VEGF-A (Mm00437304 _m1; Life Technologies). Mouse GAPDH (catalogue No. 4352339E; Life Technologies) was used as a reference gene. Gene expression changes in the retinas of oxygen-exposed mice were normalized using values from room air-exposed mice.
In Situ Superoxide Detection
Dihydroethidium (DHE, 5 lM; Life Technologies) was used as described previously to detect superoxide in fresh frozen eye sections (10 lm). 16 Sections preincubated with a superoxide dismutase mimetic MnTmPyP (10 lM; Sapphire Bioscience, Waterloo, New South Wales, Australia) were used as background controls (data not shown). Sections were viewed under a fluorescence microscope (excitation 546 nm, detection 590 nm) and all images were taken with uniform exposure settings (100 ms). The fluorescence intensity of retinal sections was measured with ImageJ software (National Institutes of Health) 15 and data were normalized using values from room air-exposed mice.
Immunohistochemical Detection of Macrophages
The PFA (4%)-fixed flat mounts were blocked with 4% BSA (Sigma-Aldrich) with 0.4% Triton X-100 for 60 minutes at room temperature, and then coincubated overnight (48C) with fluorophore-conjugated isolectin B4 (5 lg/mL), and an antibody with specificity for ionized calcium binding adaptor molecule 1 (Iba-1) expressed by macrophages and microglia (rabbit antimouse polyclonal Iba-1 antibody, 0.5 lg/mL, catalogue No. 019-19741; Wako Pure Chemical Industry, Osaka, Japan). Sections then were incubated with a secondary antibody (goat anti-rabbit Cy3 antibody, 1:300; Vector Laboratories, Burlingame, CA) for 1 hour and mounted in Dako fluorescent mounting media (Dako). Rabbit IgG (Dako) was used as a negative control. Six to eight images (320 magnification, 680 3 510 lm) were selected randomly to estimate the total number of Iba-1-positive (Iba-1þ) cells in each retina. Average values were expressed as the number of Iba-1þ cells per field.
Statistics
Mice were taken from at least three different litters for each experimental method. Between 6 and 20 mice were used for each experiment (see results for details). Data are expressed as mean 6 SEM. Mean data were analyzed with unpaired t-tests or 1-way ANOVA followed by post hoc Tukey analysis (GraphPad Prism 6.0). A value of P < 0.05 was regarded as statistically significant. Fig. S3 ). As hypoxia-induced neovascularization in OIR has been shown to vary with the extent of hyperoxia- induced vaso-obliteration, 14 we compared the extent of vasoobliteration between Nox2 KO and WT mice at P8 (see Supplementary Fig. S4 ). Mice of both genotypes demonstrated comparable vaso-obliteration at P8 (WT, 50.08 6 1.43%, n ¼ 14 versus Nox2 KO, 49.16 6 1.76%; n ¼ 19; P ¼ 0.70), suggesting that differential vaso-obliteration did not account for the observed differences in neovascularization at P17. Each genotype showed similar body weights on tissue harvest at P8 (WT, 5.07 6 0.36 g, n ¼ 14 versus Nox2 KO, 4.53 6 0.16 g, n ¼ 19; P > 1.00) and at P17 (WT, 6.69 6 0.20 g, n ¼ 16 versus Nox2 KO, 6.65 6 0.15 g; n ¼ 20; P ¼ 0.47).
RESULTS
Retinal Neovascularization Was Suppressed in
Upregulation of Gene Expression of Nox2 and VEGF-A in OIR
Recently, Nox2 and VEGF have been shown to be involved in ischemia-induced angiogenesis in a mouse hind limb model, 9 and VEGF is well known as a key regulator of retinal neovascularization in OIR. 5 We, therefore, quantified the expression of Nox2 and VEGF-A mRNA in mouse retinas with quantitative RT-PCR at P8 (hyperoxia) and P17 (relative hypoxia). There was no difference in the expression of Nox2 at P8 between WT mice raised in room air and those exposed to hyperoxia (OIR group, Fig. 2A ). In contrast, Nox2 mRNA was significantly higher in OIR WT mice than in controls at P17, a time by which peak neovascularization had occurred (Fig. 2A) . The VEGF-A gene expression was suppressed in hyperoxia (P8) and was induced after a period of relative hypoxia (P17, Fig. 2B) , consistent with the known expression profile of VEGF-A in mouse OIR. 5 Importantly, Nox2 KO mice did not exhibit hypoxia-induced VEGF gene expression at P17, implicating Nox2 in the regulation of VEGF expression (Fig.  2B ).
Superoxide Generation in Retinas Was Reduced in Nox2 KO Mice With OIR
Retinal superoxide accumulation was detected with DHE staining in fresh frozen eye sections to determine the enzyme activity of Nox (Fig. 3) .
Minimal fluorescence was detected in the retinal sections of WT and Nox2 KO mice raised in room air (Figs. 3A, 3B ). The DHE fluorescence was increased significantly in the retinas of WT mice with OIR when compared to those raised in room air (OIR, 2.72 6 0.18-fold, n ¼ 7 versus normoxic, 1.00 6 0.67-fold, n ¼ 4; P ¼ 0.01; Fig. 3E ). The DHE fluorescence was most intense in the ganglion cell layer (GCL), in association with neovascular tufts, as well as in the inner (INL) and outer (ONL) nuclear layers (Fig. 3C) . In contrast, OIR in Nox2 KO mice was not associated with an increase in DHE fluorescence (OIR, 1.14 6 0.22-fold; n ¼ 6 versus normoxia, 1.00 6 0.17-fold; n ¼ 6; P ¼ 0.63). Accordingly, DHE fluorescence appeared to be lower in the GCL of Nox2 KO mice with OIR than in WT mice with OIR (Fig. 3D) .
Accumulation of Iba-1 Positive Macrophages and Microglia in P17 Retinas With OIR Was Reduced in Nox2 KO Mice
Retinal microglia and macrophages are known to have important roles in the neovascularization that occurs in the mouse model of OIR.
11 Therefore, we looked for macrophages and microglia in P17 retinal flat mounts using an Iba-1 antibody (Fig. 4) . There was a significant increase in density of macrophages and microglia in the retinas of WT mice with OIR when compared to those of mice raised in room air (number of Iba-1þ cells, normoxia 27 6 1, n ¼ 9 versus OIR 49 6 3, n ¼ 10; P < 0.0001; Fig. 4A ). The Iba-1þ cells were colocalized predominantly with neovascular tufts (Figs. 4B-E) , reflecting the known roles of these cells in neovascularization in OIR. In contrast, few Iba-1þ cells were seen in the retinas of Nox2 KO mice with OIR (number of Iba-1þ cells, normoxia 30 6 1, n ¼ 9 versus OIR 33 6 2, n ¼ 14; P ¼ 0.31; Fig. 4A ).
DISCUSSION
The aberrant growth of new blood vessels in proliferative eye diseases is preceded by a period of hypoxia that triggers the release of growth factors, including VEGF. 1 The VEGF has angiogenic and proinflammatory actions, increasing vascular permeability, and it remains a key mediator of retinal neovascularization. 2 We have identified a mechanism by which Nox2-generated ROS facilitates VEGF-mediated retinal neovascularization in a mouse model of OIR. The reduction in retinal neovascularization in Nox2 KO mice with OIR was associated with a decrease in the accumulation of Iba-1þ macrophages and microglia, pointing to a role for these inflammatory cells in FIGURE 2. Retinal Nox2 and VEGF-A mRNA expression at P8 and P17. Retinal Nox2 mRNA expression was comparable in WT mice exposed to either room air or hyperoxia (P8). At P17, following a period of relative hypoxia, Nox2 mRNA expression was significantly higher in WT mice with OIR than in WT mice raised in room air (normoxia [A]). The VEGF-A mRNA expression was significantly and comparably reduced in WT mice and Nox2 KO mice exposed to hyperoxia (P8), relative to genotype-matched controls. Marked induction of VEGF-A mRNA expression was detected in WT mice with OIR, but not in Nox2 KO mice with OIR, relative to their genotype-matched controls raised in room air (B). *P < 0.05, n ¼ 6 to 9 mice/group. the development of new vessels. Inhibitors of this pathway, therefore, may represent an additional means of suppressing neovascularization and inflammation associated with retinal eye disease.
Studies of inhibitors of Nox and antioxidants, including siRNA targeting Nox subunits p22phox, 17 as well as the antioxidant and a nonselective inhibitor apocynin, 6 have demonstrated a role for the Nox enzyme complex and ROS in mouse models of retinal and choroidal neovascularization. Al-Shabrawey et al. 6 showed that the antioxidant apocynin, which also blocks Nox activation, suppressed ROS generation, retinal VEGF expression, and neovascularization in OIR model. We extended their findings by showing that Nox2 activation is an important component of retinal neovascularization. While Al-Shabrawey et al. 6 demonstrated that vascular endothelial cells contributed to hypoxia-induced activation of Nox, we found reductions in superoxide production and Iba-1þ cell accumulation in the hypoxic retina in Nox2 KO, suggesting an association between Nox2-generated ROS from Iba-1þ macrophages and microglia, and neovessels in OIR. Our finding also is consistent with a recent study by Zhang et al., 18 which demonstrated that suppressing the expression of Rac mRNA with shRNA reduced VEGF protein levels in hypoxic retinas. It also has been demonstrated that inactivation of Nox achieved by deletion of the Nox cytosolic subunit p47phox suppresses choroidal neovascularization in mice. 19 Five isoforms of Nox (Nox1, Nox2, Nox3, Nox4, and Nox5) have been identified in different tissues, and each isoform requires different subunits for full activation. 20 The p22phox is an integral functional subunit for Nox1, Nox2, Nox3, and Nox4, while p47phox and Rac are required by Nox1 and Nox2 for effective ROS generation when the enzyme is activated, for example by growth factors, like VEGF or stimuli, such as hypoxia. 20 While all of these studies have firmly established a role for Nox in retinal neovascularization, 6 ,17-19 they did not identify the isoform of Nox that is responsible for these effects. Our study established that Nox2 is a key mediator of retinal neovascularization in mouse OIR.
The reduction in retinal neovascularization observed in Nox2 KO mice with OIR implicates Nox2 in hypoxia-induced neovascularization. The VEGF is a mediator of retinal neovascularization in OIR, 4, 5 and ROS production has been shown to induce VEGF expression by retinal vascular endothelial cells in hypoxia 6, 7 and in pulmonary vessels in a mouse model of hypoxic lung injury. 21 We have demonstrated that the expression of VEGF-A and Nox2 mRNA, as well as the production of superoxide were higher in the hypoxic mouse retina than in age-matched normoxic controls. In the absence of Nox2 gene expression, the stimulatory effect of hypoxia on VEGF-A mRNA expression and ROS production was attenuated significantly. These observations indicated that Nox2 is a major source of ROS production and a driver of VEGF expression in hypoxia. In keeping with these findings, in vitro studies have demonstrated that hypoxia enhances Nox2 protein expression in retinal vascular endothelial cells 7 and the inhibition of Nox2 activity suppresses hypoxia-induced VEGF expression. 6 Thus, it is apparent that Nox2-dependent ROS production is involved in the induction of retinal VEGF expression by hypoxia.
Hypoxia also is known to stimulate the expression of VEGF in developmental retinal vascularization and in pathologic neovascularization via stabilization of hypoxia-inducible factor (HIF-1a). 22, 23 The inhibition of retinal HIF-1a gene expression in mice is known to reduce retinal VEGF expression and neovascularization. 23 Further, ROS are known to induce the expression of HIF-1a and stabilize HIF-1a mRNA in hypoxia in vivo 7 and in vitro, 21 with concomitant upregulation of VEGF. Moreover, Diebold et al. 24 showed that the expression of HIF1a protein in a mouse model of subcutaneous angiogenesis was significantly lower in Nox2 KO mice than in WT controls, consistent with the conclusion that Nox2 and ROS generation are involved in the expression of HIF-1a. Furthermore, it is likely that Nox2 enhances VEGF-dependent retinal neovascularization by interfering downstream with protein tyrosine phosphatases (PTPs), which are negative modulators of the VEGF receptor VEGFR2 signaling. 25 This is achieved by oxidation of crucial cysteine residues in PTPs, thus, inactivating them, and promoting VEGFR2 phosphorylation and signaling. 24 The prevention of hyperoxia-induced vaso-obliteration is known to attenuate hypoxia-induced neovascularization in mouse OIR. 14 We have demonstrated that Nox2 KO and WT mice are equally prone to hyperoxia-induced vaso-obliteration at P8, excluding this as a driver for the differences observed in the extent of retinal neovascularization at P17. Interestingly, Saito et al. 26 found that intraperitoneal administration of apocynin during and after the phase of hyperoxia in a rat model of OIR reduced the retinal avascular area, without affecting VEGF protein expression and intravitreal neovascularization at 4 days after the phase of hyperoxia. In a different study, Saito et al. 27 found that supplementary oxygen given for 4 days after the phase of hyperoxia enhanced the phosphorylation of p47phox, indicating an activation of Nox. Because apocynin blocks the activation of other Nox isoforms, the contribution of other isoforms cannot be ruled out.
We have demonstrated that the accumulation of Iba-1þ macrophages and microglia in the hypoxic retina of Nox2 KO mice was significantly lower than that seen in WT mice. As macrophages and microglia are known to be important drivers of retinal neovascularization in OIR, 11 this observation may account in part for the reduction in neovascularization seen in Nox2 KO mice. Expression of the macrophage chemoattractant protein CCL2 is known to be enhanced during the neovascular phase of OIR, 11 and Nox2 also might be involved in CCL2 expression. In support of this hypothesis, renal expression of CCL2 is lower in Nox2 KO mice than WT mice in the setting of diabetes. 28 Furthermore, endothelial overexpression of Nox2 following arterial injury increases macrophage adhesion. 29 Thus, the proinflammatory actions of Nox2 may well contribute to hypoxia-induced retinal neovascularization. 11 We have found that superoxide generation, as evidenced by DHE fluorescence, was predominantly localized in the GCL, and the INL and ONL during the period of neovascularization in OIR. This expression pattern bears close resemblance to the distribution of macrophages and microglia in retinal cross sections from mice with OIR. 11 Other work has demonstrated colocalization of Nox2 with the endothelial cell marker CD31 in neovascular tufts in OIR, and Nox2 is known to be expressed in endothelial cells and inflammatory cells. 30 Therefore, it is likely that Nox2-generated ROS from endothelial 6 and inflammatory cells are involved intimately in the development of retinal neovascularization in OIR.
In conclusion, our findings demonstrated that Nox2-generated ROS are important mediators of hypoxia-induced retinal neovascularization. The Iba-1þ macrophages and microglia appear to be one of the key sources of Nox2-generated ROS. Therapies that target Nox2 directly might well prove to be valuable in the management of aberrant ocular neovascularization and inflammation. ment of Innovation, Industry, and Regional Development's
